Israel Active

Tel Aviv University Professor Neta Erez made the unusual offer on Reddit.com to answer any questions in one day, about her specialty of cancer research. She answered 61 tough questions.

Four women from Israel’s diverse, inclusive society enthusiastically speak about their life-saving work as volunteer paramedics with Israeli emergency service United Hatzalah.

Some 600,000 hysterectomies are performed annually in the US. The US FDA has just approved the Hominis Surgical System, developed by Israel’s Memic. The surgeon operates using the Robotically Assisted Surgical Device (RASD) via tiny incisions in the patient’s body.

Israeli startup ForSight Robotics is developing a microsurgical robotic platform for eye surgery. The platform will exceed human surgical capabilities with unprecedented dexterity and maneuverability to within only a few microns.

Israel’s Belkin Laser (reported previously) is conducting a large-scale clinical study of its Eagle laser glaucoma treatment in Europe and Israel. Patients at more than 10 sites are testing the computer-guided device that uses healing lasers far less intrusively than currently approved devices.

Scientists at Ben Gurion University have confirmed the diagnosis of Alzheimer’s disease, epilepsy, traumatic brain injury and stroke from electroencephalogram (EEG) patterns. Analysis of changes in brain blood vessel pathology can provide fast diagnosis of those conditions.

Arab-Israeli Professor Ashraf Brik (see previously) of Israel’s Technion and his team have overcome a 60-year technical problem to synthesize plectasin, a peptide with promising antibiotic results against multi-resistant bacteria, and linaclotide, to treat irritable bowel syndrome.

IDC Herzliya researchers at Israel’s MIGAL laboratory, with Icelandic scientists, have identified that spirulina algae can reduce the cytokine storm that kills Covid-19 patients. The algae was supplied by Israel’s VAXA (Iceland based) who have EU funding to find natural cures for Covid-19.

Israel's Sheba Medical Center is partnering Israel’s Inspira Technologies in trials of its new respiratory treatment for Covid-19 patients suffering from acute breathing difficulties. The Augmented Respiration Treatment (ART) directly oxygenates blood while the patient remains conscious.

Israeli biotech Pepticom (reported previously) has raised $2.6 million to establish a company that can treat SARS-Cov-2 and its mutations. It will implement AI technology to design, discover and develop novel peptide molecules.